Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-09-208471
Filing Date
2009-10-15
Accepted
2009-10-15 15:58:47
Documents
3
Group Members
INVUS ADVISORS, L.L.C.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.RAYMOND DEBBANEULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D dsc13da.htm SC 13D/A 166834
2 PURCHASE AGREEMENT dex999.htm EX-99.9 12171
3 PURCHASE AGREEMENT SUPPLEMENT dex9910.htm EX-99.10 10156
  Complete submission text file 0001193125-09-208471.txt   191370
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Subject) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 091121504
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE INVUS GROUP, L.L.C. 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, L.L.C. 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212 371 1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

EIN.: 830359143
Type: SC 13D/A